Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Prima Andalan Mandiri Tbk. (MCOL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Prima Andalan Mandiri Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B), while Prima Andalan Mandiri Tbk. trades at Rp3,750 (market cap 13.33T). The key difference: Prima Andalan Mandiri Tbk. is far larger — about 41.8× Diagnos Laboratorium Utama Tbk.'s market cap. Which is the better fit depends on your goals.
| DGNS | MCOL | |
|---|---|---|
Market Cap | 319B | 13.33T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Prima Andalan Mandiri Tbk.
PT Prima Andalan Mandiri Tbk (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Nurul Hidajati Handoko, S.H., No. 1 dated June 1, 2005. The Company started commercial activities in 2011.
Read more on MCOL →
